Acquisition Dr. Reddy’s Plans Acquisition of OctoPlus
Dr. Reddy’s Laboratories plans to OctoPlus N.V. a service based specialty pharmaceutical company, for OctoPlus N.V. , for an offer price of € 27.39 million. This deal will help expand the expertise and scientific capabilities of Dr. Reddy's.
Hyderabad/India – G V Prasad, Vice-Chairman and CEO of Dr. Reddy’s said, “As we globalize our R & D efforts, we are looking forward to build a research base in Leiden (Netherlands). The acquisition helps us ramp up our technology capabilities in drug delivery.”